Laboratory Question for the Week of December 26, 2022
Are there any updates regarding the Clinical Laboratory Fee Schedule for 2023?
Are there any updates regarding the Clinical Laboratory Fee Schedule for 2023?
Are there any QPP Measure additions for pathology in 2023?
Is there coverage for initial screening for hepatitis C virus (HCV) for adults at high risk for HCV infection?
Can we code diagnoses with terms documented such as “probable,” and “suspected?”
When testing is conducted on a single specimen source such as urine, do we need to report a modifier?
What is the Saving Access to Laboratory Service Act?
What types of tests will be impacted by lab reimbursement cuts if these cuts are finalized for next year?
Do we need a modifier for the submitting claims for screening of Medicare beneficiaries diagnosed with pre-diabetes?
For postmortem examination coding, how are the terms newborn, infant, and macerated stillborn defined?
Can we report 88380 in conjunction with 88381?
When billing for 88362 and 88380 on the same date of service what should we include in the documentation? Is a modifier necessary?
Do any new codes exist for reporting the transfusion of medicine-related GSP services?
CPT® copyright 2022 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 445 Minnesota Street, Suite 514
St. Paul, MN 55101
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT